Linezolid Duration for Wound Infections
For wound infections, administer linezolid 600 mg PO every 12 hours for 7-14 days, with the specific duration determined by infection severity and clinical response.
Evidence-Based Duration Guidelines
The IDSA guidelines for MRSA skin and soft tissue infections provide clear direction 1:
- Mild-to-moderate wound infections: 5-10 days is typically sufficient
- Complicated skin and soft tissue infections (cSSTI): 7-14 days is recommended, including deep soft-tissue infections, surgical/traumatic wound infections, major abscesses, cellulitis, infected ulcers, and burns 1
The 2014 IDSA SSTI guidelines 2 and 2005 guidelines 3 consistently support this 7-14 day range for complicated infections, noting that duration should be individualized based on clinical response but providing this specific timeframe as the standard.
Dosing Confirmation
The standard adult dose of 600 mg PO/IV every 12 hours is well-established across multiple IDSA guidelines 1 with BII/CIII evidence strength for wound infections and cSSTI. The FDA label confirms excellent oral bioavailability (~100%), allowing seamless transition between IV and oral routes without dose adjustment 4.
Clinical Decision Algorithm
Start with 7 days and extend based on:
- Presence of deeper tissue involvement (fascia, muscle) → extend toward 14 days
- Adequacy of surgical debridement (if performed) → complete debridement allows shorter duration
- Rate of clinical improvement → slow response requires longer treatment
- Presence of osteomyelitis → requires 4-6 weeks minimum 5
- Immunocompromised status → consider extending duration
Critical Caveats
Do not exceed 28 days without compelling indication. Research demonstrates that linezolid toxicity (bone marrow suppression, peripheral neuropathy) increases significantly with prolonged use 6, 7. Studies show adverse events including mild bone marrow suppression and elevated liver enzymes even with appropriate duration 6.
Monitor for toxicity if treatment extends beyond 14 days, particularly:
- Complete blood counts (thrombocytopenia, anemia)
- Neurologic symptoms (peripheral or optic neuropathy)
- Liver function tests
Surgical intervention is paramount. The guidelines emphasize that for complicated wound infections, surgical debridement combined with antibiotics is essential 1. Antibiotics alone are insufficient for deep abscesses, extensive necrosis, or necrotizing infections.
Special Populations
For pediatric patients >12 years: same adult dosing (600 mg every 12 hours) 1
For children <12 years: 10 mg/kg/dose every 8 hours, not exceeding 600 mg/dose 1
Renal adjustment: No dose adjustment needed for standard renal impairment, though recent research suggests consideration of 400 mg every 12 hours for CrCL ≤30 mL/min 8